Identification of TP53 mutation-associated prognostic genes and investigation of the immune cell infiltration in patients with hepatocellular carcinoma

被引：0
作者：
Yang, Qijun [1 ]
Gao, Lianke [3 ]
Xu, Yuhan [2 ]
Cao, Gaoquan [4 ]
He, Yingcheng
Zhang, Wenyige [2 ]
Zhang, Xue [2 ]
Wu, Chengfeng [5 ]
Liao, Kaili [1 ]
Wang, Xiaozhong [1 ]
机构：
[1] Nanchang Univ, Affiliated Hosp 2, Dept Clin Lab, Nanchang 330006, Jiangxi, Peoples R China
[2] Nanchang Univ, Queen Mary Coll, Nanchang 330031, Jiangxi, Peoples R China
[3] Nanchang Univ, Adv Mfg Coll, Nanchang 330031, Jiangxi, Peoples R China
[4] Nanchang Univ, Clin Sch 4, South Rd Bayi Sq, Nanchang 330031, Jiangxi, Peoples R China
[5] Nanchang Univ, Affiliated Hosp 2, Dept Vasc Surg, Nanchang 330006, Jiangxi, Peoples R China
来源：
GENES & DISEASES | 2024年 / 11卷 / 02期
基金：
中国国家自然科学基金;
关键词：
D O I：
10.1016/j.gendis.2023.03.020
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
[No abstract available]
引用
收藏
页码：520 / 523
页数：4
相关论文
共 50 条
  • [11] Identification of immune infiltration-related genes as prognostic indicators for hepatocellular carcinoma
    Kunfu Dai
    Chao Liu
    Ge Guan
    Jinzhen Cai
    Liqun Wu
    BMC Cancer, 22
  • [12] Development and validation of a TP53-associated immune prognostic model for hepatocellular carcinoma
    Long, Junyu
    Wang, Anqiang
    Bai, Yi
    Lin, Jianzhen
    Yang, Xu
    Wang, Dongxu
    Yang, Xiaobo
    Jiang, Yan
    Zhao, Haitao
    EBIOMEDICINE, 2019, 42 : 363 - 374
  • [13] Mutations in TP53 and PIK3CA genes in hepatocellular carcinoma patients are associated with chronic Schistosomiasis
    AlGabbani, Qwait
    SAUDI JOURNAL OF BIOLOGICAL SCIENCES, 2022, 29 (02) : 848 - 853
  • [14] Rhabdomyosarcoma-Associated Renal Cell Carcinoma: A Link with Constitutional TP53 Mutation
    Curry, Sarah
    Ibrahim, Fadi
    Grehan, David
    Mcdermott, Michael
    Capra, Michael
    Betts, David
    O'Sullivan, Maureen
    PEDIATRIC AND DEVELOPMENTAL PATHOLOGY, 2011, 14 (03) : 248 - 251
  • [15] Association between TP53 R249S mutation and polymorphisms in TP53 intron 1 in hepatocellular carcinoma
    Ortiz-Cuaran, Sandra
    Cox, David
    Villar, Stephanie
    Friesen, Marlin D.
    Durand, Geoffroy
    Chabrier, Amelie
    Khuhaprema, Thiravud
    Sangrajrang, Suleeporn
    Ognjanovic, Simona
    Groopman, John D.
    Hainaut, Pierre
    Le Calvez-Kelm, Florence
    GENES CHROMOSOMES & CANCER, 2013, 52 (10) : 912 - 919
  • [16] Targeted Combination Therapies: A New Frontier in the Treatment of TP53 and KRAS Mutation-Associated Cancers
    Kargbo, Robert B.
    ACS MEDICINAL CHEMISTRY LETTERS, 2023, 15 (01): : 15 - 16
  • [17] Correlation of TP53 mutations with HCV positivity in hepatocarcinogenesis: Identification of a novel TP53 microindel in hepatocellular carcinoma with HCV infection
    Long, Jiang
    Wang, Yan
    Li, Man
    Tong, Wei-Min
    Jia, Ji-Dong
    Huang, Jian
    ONCOLOGY REPORTS, 2013, 30 (01) : 119 - 124
  • [18] The prognostic role of a novel TP53 mutation classifier in resectable esophageal squamous-cell carcinoma
    Su, Dan
    Huang, Minran
    Jin, Jiaoyue
    Wu, Yingxue
    Ying, Lisa
    Zhang, Fanrong
    Chen, Kaiyan
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [19] TP53 mutation is not an independent prognostic factor in patients with mantle cell lymphoma at advanced stage
    Hua-Jie Dong
    Li-Tao Zhou
    Cheng Fang
    Lei Fan
    Dan-Xia Zhu
    Yin-Hua Wang
    Jian-Yong Li
    Wei Xu
    Medical Oncology, 2012, 29 : 2166 - 2173
  • [20] TP53 mutation is not an independent prognostic factor in patients with mantle cell lymphoma at advanced stage
    Dong, Hua-Jie
    Zhou, Li-Tao
    Fang, Cheng
    Fan, Lei
    Zhu, Dan-Xia
    Wang, Yin-Hua
    Li, Jian-Yong
    Xu, Wei
    MEDICAL ONCOLOGY, 2012, 29 (03) : 2166 - 2173
12345